| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.08 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.08 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.08 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.09 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |